News & Analysis as of

Effective Filing Date First-to-File Anticipation

Foley & Lardner LLP

Did The PTAB Dose The AIA Poison Pill Incorrectly Against Premium Genetics?

Foley & Lardner LLP on

In Inguran, LLC v. Premium Genetics (UK) Ltd., the USPTO Patent Trial and Appeal Board (PTAB) instituted Post Grant Review (PGR) proceedings in a patent granted from an AIA transition application based on its finding that at...more

1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide